We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ZKH:NYSEZKH Group Limited Analysis

Data as of 2026-09-01 - not real-time

$2.92

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind ZKH Group Limited is neutral at $2.92, with no clear ordering between short and long averages. The last 30 days have lost 2.3%. With RSI at 52.4 the momentum picture is neutral, alongside a bearish MACD signal. Watch $2.51 as support and $3.04 as the nearer resistance level.
Valuation screens as undervalued, on a P/E of 11.9 with no clean sector comparison available. Sell-side targets cluster 46.5% above the current quote. Revenue is growing at 12.8% on a -0.0% profit margin.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 21.4%, a beta of 0.42 and a maximum drawdown of 45.6%, position sizing matters here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.

Top Market Events

SHANGHAI, Aug. 6, 2026 /PRNewswire/ -- ZKH Group Limited "ZKH" or the "Company" NYSE: ZKH , a leading maintenance,...ZKH Group Limited "ZKH" or the "Company" NYSE: ZKH , a leading maintenance, repair and operations "MRO" procurement...Yahoo Finance3monZKH Group Ltd ZKH Q1 2026 Earnings Call Highlights: A Strong Start with Record Profitability .

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 3.09
  • MACD momentum is negative
  • Thin trading liquidity raises execution risk

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 3.09
  • Analyst targets imply +46.5% versus the current price
  • MACD momentum is negative

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Negative profit margin of -0.0%
  • Analyst targets imply +46.5% versus the current price
  • Negative return on equity of -0.1%

Key Metrics & Analysis

Financial Health

Revenue Growth12.80%
Profit Margin-0.03%
P/E Ratio11.9
ROE-0.10%
ROA-0.77%
Debt/Equity13.84
P/B Ratio1.1

Technical Analysis

TrendNeutral
RSI52.4
Support$2.51
Resistance$3.04
MA 20$2.90
MA 50$2.77
MA 200$3.09
MACDBearish
VolumeIncreasing
Fear & Greed Index94.79

Valuation

Target Price$4.28
Upside/Downside46.53%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.42
Volatility21.37%
Sector RiskHigh
Reg. RiskLow
Geo RiskHigh
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.